In Reply to Belkacemi and Tsoutsou

To the Editor: We thank Belkacemi et al for their interest in our article (1, 2). We agree with them regarding the impact of regional nodal irradiation in node-positive and high-risk node-negative women; however, our target population differs from the cited trials. Details of regional nodal irradiation data are provided in Table E1. Most patients (75%) received a dedicated supraclavicular field, which often includes level III nodes. Patients had level I to II axillary dissection; therefore, only 24% received an additional axillary field.

https://ift.tt/2okNWMh